RIP kinase
RIP kinase(受体相互作用蛋白激酶)
Receptor interacting protein 2 (RIP2), a serine/threonine kinase, is an adaptor molecule of NOD1 and NOD2, and genetic variation in this receptor is known to be associated with the severity of allergic asthma in children.
Receptor interacting protein kinase 2 (RIPK2) is critical for NOD-mediated NF-κB activation and cytokine production. WEHI-345, a selective RIPK2 kinase inhibitor, which delays RIPK2 ubiquitylation and NF-κB activation downstream of NOD engagement.
Receptor interacting protein kinase 3 (RIPK3) is a cytosolic master regulator of necroptosis. RIPK3 has an active serine/threonine kinase domain at the N-terminus, and a unique protein-protein interaction domain called the RIP homotypic interaction motif (RHIM) at the C-terminus. Both kinase activity and RHIM are indispensable for necroptosis. RIPK3 interacts with other RHIM-containing proteins such as RIPK1, Toll/interleukin-1 (IL-1) receptor domain-containing adaptor protein inducing TRIF or DAI. RIPK3 induces necroptosis, a type of regulated necrosis, through its kinase domain and RHIM.
RIP kinase 相关产品(52)
- GC11008Necrostatin-1CAS: 4311-88-0纯度: >98.00% / >99.00%
Necrostatin-1主要作用于细胞中的RIP1,Necrostatin-1是一种RIP1激酶抑制剂,IC50值为0.32 mM。
- GC32775RIP2 kinase inhibitor 1CAS: 1423186-80-4纯度: >98.50%
GSK2983559 active metabolite is an active metabolite of GSK2983559, also is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
- GC32860RIP2 kinase inhibitor 2CAS: 1581270-11-2纯度: >99.50%
RIP2kinaseinhibitor2是一种受体相互作用蛋白-2(RIP2)激酶抑制剂,详细信息请参考专利WO/2014043437A1中的化合物example9。
- GC36711Necrostatin 2 racemateCAS: 852391-15-2纯度: >99.50%
Necrostatin 2 racemate是一种不影响吲哚胺2,3-双加氧酶(IDO)活性的,具有高度特异性的受体相互作用蛋白激酶1(RIPK1)抑制剂。
- GC36712Necrostatin 2 S enantiomerCAS: 852391-20-9纯度: >99.50%
Necrostatin 2 S enantiomer 是 Necrostatin 2 的 S 型异构体。Necrostatin 2 是高活性的坏死性凋亡抑制剂,为有效的 RIPK1 抑制剂,缺乏 IDO 靶向作用。
- GC37533RIP1 kinase inhibitor 1CAS: 2095515-38-9纯度: >99.50%
RIP1 kinase inhibitor 1 (compound 22) 是一种高效的,口服有效的,可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11008 | Necrostatin-1 | 4311-88-0 | >98.00% / >99.00% | |
Necrostatin-1主要作用于细胞中的RIP1,Necrostatin-1是一种RIP1激酶抑制剂,IC50值为0.32 mM。 | ||||
| GC11167 | Necrostatin 2 | 852391-19-6 | >99.50% | |
A potent inhibitor of necroptosis | ||||
| GC15291 | GSK3145095 | 1622849-43-7 | >98.00% | |
GSK3145095 是一种 RIP1 激酶抑制剂,IC50 为 6.3 nM。 | ||||
| GC15573 | GSK481 | 1622849-58-4 | >98.00% | |
A selective inhibitor of RIP1 | ||||
| GC18177 | WEHI-345 | 1354825-58-3 | >99.00% | |
An inhibitor of RIPK2 | ||||
| GC19175 | GSK-872 | 1346546-69-7 | >99.50% | |
GSK-872 是一种 RIPK3 抑制剂。 | ||||
| GC19182 | GSK2982772 | 1622848-92-3 | >99.00% | |
A RIPK1 inhibitor | ||||
| GC19185 | GSK583 | 1346547-00-9 | >98.50% | |
A selective inhibitor of RIP2 kinase | ||||
| GC19503 | GSK547 | 2226735-55-1 | >99.50% | |
GSK547 (GSK'547) 是受体相互作用的丝氨酸/苏氨酸蛋白激酶 1 (RIPK1) 的高选择性和强效抑制剂,可抑制巨噬细胞介导的胰腺癌适应性免疫耐受。 | ||||
| GC31652 | RIPA-56 | 1956370-21-0 | >99.50% | |
A RIPK1 inhibitor | ||||
| GC32280 | HS-1371 | 2158197-70-5 | >97.00% | |
A RIPK3 inhibitor | ||||
| GC32775 | RIP2 kinase inhibitor 1 | 1423186-80-4 | >98.50% | |
GSK2983559 active metabolite is an active metabolite of GSK2983559, also is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1. | ||||
| GC32860 | RIP2 kinase inhibitor 2 | 1581270-11-2 | >99.50% | |
RIP2kinaseinhibitor2是一种受体相互作用蛋白-2(RIP2)激酶抑制剂,详细信息请参考专利WO/2014043437A1中的化合物example9。 | ||||
| GC33620 | Nec-4 | 1041644-43-2 | - | |
Nec-4,一个三环衍生物,是受体相互作用蛋白1(RIP1)的一个有效抑制剂,其IC50值为2.6μM,Ki值为0.46μM。 | ||||
| GC34543 | cRIPGBM | 2361988-76-1 | - | |
cRIPGBM是RIPGBM的促凋亡衍生物,是通过与受体相互作用蛋白激酶2(RIPK2)结合,诱导GBM肿瘤干细胞凋亡的选择性诱导剂,对GBM-1细胞的EC50值为68nM。 | ||||
| GC34605 | GSK840 | 2361146-30-5 | >99.00% | |
GSK840(GSK’840)是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为0.9nM,并抑制激酶活性,IC50值为0.3nM。 | ||||
| GC34606 | GSK-843 | 1601496-05-2 | >98.00% | |
GSK-843是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为8.6nM,并抑制激酶活性,IC50值为6.5nM。 | ||||
| GC36170 | GNE684 | 2438637-64-8 | - | |
GNE684 是一种有效的受体相互作用蛋白 1 (RIP1) 抑制剂,作用于人类、小鼠与大鼠 RIP1 的 Kiapp 值分别为 21 nM、189 nM 和 691 nM。 | ||||
| GC36189 | GSK2983559 | 1579965-12-0 | >98.00% | |
A RIPK2 inhibitor | ||||
| GC36711 | Necrostatin 2 racemate | 852391-15-2 | >99.50% | |
Necrostatin 2 racemate是一种不影响吲哚胺2,3-双加氧酶(IDO)活性的,具有高度特异性的受体相互作用蛋白激酶1(RIPK1)抑制剂。 | ||||
| GC36712 | Necrostatin 2 S enantiomer | 852391-20-9 | >99.50% | |
Necrostatin 2 S enantiomer 是 Necrostatin 2 的 S 型异构体。Necrostatin 2 是高活性的坏死性凋亡抑制剂,为有效的 RIPK1 抑制剂,缺乏 IDO 靶向作用。 | ||||
| GC36933 | PK68 | 2173556-69-7 | >99.50% | |
PK68 is a potent orally active and specific inhibitor of receptor-interacting kinase 1 (RIPK1) with an IC50 of ~90?nM. | ||||
| GC37533 | RIP1 kinase inhibitor 1 | 2095515-38-9 | >99.50% | |
RIP1 kinase inhibitor 1 (compound 22) 是一种高效的,口服有效的,可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。 | ||||
| GC37535 | RIPK1-IN-3 | 2242677-36-5 | - | |
RIPK1-IN-3 (Example 38) 是RIPK1 的抑制剂,信息来自专利WO2018148626A1,拥有抗炎活性。 | ||||
